Summary of Significant Accounting Policies (Details) - Schedule of Potential Common Stock Equivalents Outstanding - shares	3 Months Ended
Mar. 31, 2024	Mar. 31, 2023
Schedule of Potential Common Stock Equivalents Outstanding [Line Items]
Potential common stock equivalents outstanding	639,032	434,844
Stock Option [Member]
Schedule of Potential Common Stock Equivalents Outstanding [Line Items]
Potential common stock equivalents outstanding	233,340	204,932
Warrants [Member]
Schedule of Potential Common Stock Equivalents Outstanding [Line Items]
Potential common stock equivalents outstanding	405,692	229,912

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration